Lower THBS2 expression was linked to advanced disease status and slower tumour regression after preoperative neoadjuvant concurrent chemoradiotherapy, THBS2 acted as an independent negative prognostic factor in rectal cancer.51 The gene discussed is THBS2; the disease is rectal cancer.